Published in Breast J on February 26, 2007
Atypical hyperplasia of the breast--risk assessment and management options. N Engl J Med (2015) 3.57
Clinical characteristics of breast cancers in African-American women with benign breast disease: a comparison to the surveillance, epidemiology, and end results program. Breast J (2014) 1.39
Risk factors for breast cancer from benign breast disease in a diverse population. Breast Cancer Res Treat (2008) 1.15
The influence of family history and histological stratification on breast cancer risk in women with benign breast disease: a meta-analysis. J Cancer Res Clin Oncol (2011) 1.03
Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of women. Cancer (2016) 1.02
Benign breast disease and the risk of subsequent breast cancer in African American women. Cancer Prev Res (Phila) (2012) 0.89
Benign breast disease heterogeneity: association with histopathology, age, and ethnicity. Breast Cancer Res Treat (2007) 0.89
DNA repair gene variants associated with benign breast disease in high cancer risk women. Cancer Epidemiol Biomarkers Prev (2009) 0.82
Benign breast disease and subsequent breast cancer: English record linkage studies. J Public Health (Oxf) (2010) 0.82
p53 nuclear accumulation and ERalpha expression in ductal hyperplasia of breast in a cohort of 215 Chinese women. J Exp Clin Cancer Res (2010) 0.80
Benign breast disease: emerging findings in a diverse population. Breast J (2007) 0.79
Impact of preventive therapy on the risk of breast cancer among women with benign breast disease. Breast (2015) 0.79
Short-term imaging follow-up of patients with concordant benign breast core needle biopsies: is it really worth it? Diagn Interv Radiol (2014) 0.75
Radial scars and subsequent breast cancer risk: a meta-analysis. PLoS One (2014) 0.75
Serum IGFBP-2 and Risk of Atypical Hyperplasia of the Breast. J Cancer Epidemiol (2015) 0.75
Positive Association of Fibroadenomatoid Change with HER2-Negative Invasive Breast Cancer: A Co-Occurrence Study. PLoS One (2015) 0.75
Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med (1985) 7.22
Benign breast disease and the risk of breast cancer. N Engl J Med (2005) 6.84
Etiology of human breast cancer: a review. J Natl Cancer Inst (1973) 5.88
An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst (1975) 4.22
Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer (1985) 3.92
Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer (1993) 3.33
A prospective study of benign breast disease and the risk of breast cancer. JAMA (1992) 3.29
Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med (1994) 3.09
CYSTIC DISEASE OF THE BREAST: RELATIONSHIP TO CARCINOMA. Cancer (1964) 2.63
Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N Engl J Med (1999) 2.45
Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med (1998) 2.38
A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol (1988) 2.20
Trends in breast cancer by race and ethnicity. CA Cancer J Clin (2004) 2.19
Relation between component parts of fibrocystic disease complex and breast cancer. J Natl Cancer Inst (1978) 1.82
Association of atypical characteristics of benign breast lesions with subsequent risk of breast cancer. Cancer (1972) 1.70
Risk of breast cancer in women with benign breast disease. J Natl Cancer Inst (1980) 1.54
Chronic mastitis and carcinoma of the breast. Lancet (1976) 1.51
Is 'fibrocystic disease' of the breast precancerous? Arch Pathol Lab Med (1986) 1.23
Lower-category benign breast disease and the risk of invasive breast cancer. J Natl Cancer Inst (2004) 1.19
Risk of breast cancer after benign breast diseases. Variation by histologic type, degree of atypia, age at biopsy, and length of follow-up. Am J Epidemiol (1992) 1.17
Chronic mastopathy and breast cancer. A follow-up study. Cancer (1977) 1.09
Biopsy confirmed benign breast disease, postmenopausal use of exogenous female hormones, and breast carcinoma risk. Cancer (2000) 0.94
Benign breast lesions and subsequent breast carcinoma in Rochester, Minnesota. Mayo Clin Proc (1975) 0.94
Risk factors for breast cancer: a tabular summary of the epidemiological literature. Br J Surg (1981) 0.92
Estrogen replacement therapy in women with a history of proliferative breast disease. Cancer (1999) 0.92
Benign breast disease, recent alcohol consumption, and risk of breast cancer: a nested case-control study. Breast Cancer Res (2005) 0.88
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet (2004) 12.92
Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ Res (2003) 4.29
Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol (2003) 3.54
A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates. Proc Natl Acad Sci U S A (2009) 3.39
Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia (2005) 2.68
Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice. J Cereb Blood Flow Metab (2005) 2.65
Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J Neurosci Res (2003) 2.61
Five-year follow-up of trial of replication-competent adenovirus-mediated suicide gene therapy for treatment of prostate cancer. Mol Ther (2007) 2.44
A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia. J Neurosci Methods (2002) 2.35
Sildenafil (Viagra) induces neurogenesis and promotes functional recovery after stroke in rats. Stroke (2002) 2.24
Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon Alfa-2b compared with high-dose interferon Alfa-2b for Resected stage III cutaneous melanoma. J Clin Oncol (2007) 2.19
Challenges for multilevel health disparities research in a transdisciplinary environment. Am J Prev Med (2008) 2.17
Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells. Neurosurgery (2003) 2.16
Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence. Clin Infect Dis (2012) 2.15
Sleep in lifetime posttraumatic stress disorder: a community-based polysomnographic study. Arch Gen Psychiatry (2004) 2.13
Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice. Exp Neurol (2005) 2.11
Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J Cereb Blood Flow Metab (2006) 2.10
Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays. Cancer Res (2006) 2.08
Cost effectiveness of guanfacine extended-release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder: application of a matching-adjusted indirect comparison. Appl Health Econ Health Policy (2012) 2.06
False-negative core needle biopsies of the breast: an analysis of clinical, radiologic, and pathologic findings in 27 concecutive cases of missed breast cancer. Cancer (2003) 1.92
Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer. Cancer Res (2006) 1.83
Baseline characteristics and mortality among people in care for chronic viral hepatitis: the chronic hepatitis cohort study. Clin Infect Dis (2012) 1.79
Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke. Circulation (2003) 1.77
Second hip fracture in older men and women: the Framingham Study. Arch Intern Med (2007) 1.72
MRI detects white matter reorganization after neural progenitor cell treatment of stroke. Neuroimage (2006) 1.69
Phase I study of noninvasive imaging of adenovirus-mediated gene expression in the human prostate. Mol Ther (2008) 1.67
Coupling of angiogenesis and neurogenesis in cultured endothelial cells and neural progenitor cells after stroke. J Cereb Blood Flow Metab (2007) 1.64
Who's in favor of translational cell therapy for stroke: STEPS forward please? Cell Transplant (2009) 1.60
One-year follow-up after bone marrow stromal cell treatment in middle-aged female rats with stroke. Stroke (2007) 1.57
Stroke transiently increases subventricular zone cell division from asymmetric to symmetric and increases neuronal differentiation in the adult rat. J Neurosci (2004) 1.55
Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer. Cancer Res (2002) 1.55
Endothelial nitric oxide synthase regulates brain-derived neurotrophic factor expression and neurogenesis after stroke in mice. J Neurosci (2005) 1.54
Model selection in magnetic resonance imaging measurements of vascular permeability: Gadomer in a 9L model of rat cerebral tumor. J Cereb Blood Flow Metab (2006) 1.51
Hair care practices and their association with scalp and hair disorders in African American girls. J Am Acad Dermatol (2010) 1.48
Dialysis dose scaled to body surface area and size-adjusted, sex-specific patient mortality. Clin J Am Soc Nephrol (2012) 1.47
Late diagnosis of hepatitis C virus infection in the Chronic Hepatitis Cohort Study (CHeCS): Missed opportunities for intervention. Hepatology (2015) 1.47
Myocardial infarction and cardiac remodelling in mice. Exp Physiol (2002) 1.46
Effects of administration route on migration and distribution of neural progenitor cells transplanted into rats with focal cerebral ischemia, an MRI study. J Cereb Blood Flow Metab (2009) 1.43
Phase I trial of replication-competent adenovirus-mediated suicide gene therapy combined with IMRT for prostate cancer. Mol Ther (2007) 1.43
Increased exhaled nitric oxide following autologous peripheral hematopoietic stem-cell transplantation: a potential marker of idiopathic pneumonia syndrome. Chest (2004) 1.41
Investigation of neural progenitor cell induced angiogenesis after embolic stroke in rat using MRI. Neuroimage (2005) 1.41
Ethnic differences in survival among women with ovarian carcinoma. Cancer (2002) 1.40
Treatment of acute stroke with recombinant tissue plasminogen activator and abciximab. Acad Emerg Med (2003) 1.40
High-resolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in the MCF10 model. Breast Cancer Res Treat (2006) 1.40
Erythropoietin treatment improves neurological functional recovery in EAE mice. Brain Res (2005) 1.36
Autoantibody approach for serum-based detection of head and neck cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.35
Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice. J Neurosci Res (2006) 1.34
Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis. Proc Natl Acad Sci U S A (2003) 1.34
Combination therapy of stroke in rats with a nitric oxide donor and human bone marrow stromal cells enhances angiogenesis and neurogenesis. Brain Res (2004) 1.33
A novel signaling axis of matriptase/PDGF-D/ß-PDGFR in human prostate cancer. Cancer Res (2010) 1.32
CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity. Acta Neuropathol (2014) 1.28
Expression of insulin-like growth factor 1 and receptor in ischemic rats treated with human marrow stromal cells. Brain Res (2004) 1.28
Niaspan increases angiogenesis and improves functional recovery after stroke. Ann Neurol (2007) 1.27
Phenotypic annotation of the mouse X chromosome. Genome Res (2010) 1.26
Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat. Circulation (2005) 1.26
Bone marrow stromal cells enhance inter- and intracortical axonal connections after ischemic stroke in adult rats. J Cereb Blood Flow Metab (2010) 1.24
Correction and use of biomedical literature affected by scientific misconduct. Sci Eng Ethics (2007) 1.24
Axonal sprouting into the denervated spinal cord and synaptic and postsynaptic protein expression in the spinal cord after transplantation of bone marrow stromal cell in stroke rats. Brain Res (2007) 1.22
Atorvastatin reduction of intravascular thrombosis, increase in cerebral microvascular patency and integrity, and enhancement of spatial learning in rats subjected to traumatic brain injury. J Neurosurg (2004) 1.22
Erythropoietin amplifies stroke-induced oligodendrogenesis in the rat. PLoS One (2010) 1.20
Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort. Clin Infect Dis (2013) 1.20
Angiogenesis and improved cerebral blood flow in the ischemic boundary area detected by MRI after administration of sildenafil to rats with embolic stroke. Brain Res (2006) 1.19
MRI identification of white matter reorganization enhanced by erythropoietin treatment in a rat model of focal ischemia. Stroke (2009) 1.19
Ischemic cerebral tissue and MCP-1 enhance rat bone marrow stromal cell migration in interface culture. Exp Hematol (2002) 1.18
Evaluation of a web-based asthma management intervention program for urban teenagers: reaching the hard to reach. J Adolesc Health (2012) 1.18
Influence of health insurance status on inclusion of HER-2/neu testing in the diagnostic workup of breast cancer patients. Int J Qual Health Care (2004) 1.17
Risk factors for breast cancer from benign breast disease in a diverse population. Breast Cancer Res Treat (2008) 1.15
Bone marrow stromal cells increase oligodendrogenesis after stroke. J Cereb Blood Flow Metab (2009) 1.15
Feasibility of adenovirus-mediated hNIS gene transfer and 131I radioiodine therapy as a definitive treatment for localized prostate cancer. Mol Ther (2011) 1.14
Analysis of citations to biomedical articles affected by scientific misconduct. Sci Eng Ethics (2009) 1.13
Potential of stem/progenitor cells in treating stroke: the missing steps in translating cell therapy from laboratory to clinic. Regen Med (2008) 1.13
Second-generation replication-competent oncolytic adenovirus armed with improved suicide genes and ADP gene demonstrates greater efficacy without increased toxicity. Mol Ther (2005) 1.13
Nitric oxide donor upregulation of stromal cell-derived factor-1/chemokine (CXC motif) receptor 4 enhances bone marrow stromal cell migration into ischemic brain after stroke. Stem Cells (2007) 1.13
Comparison of bone marrow stromal cells derived from stroke and normal rats for stroke treatment. Stroke (2010) 1.12
Effects of a selective CD11b/CD18 antagonist and recombinant human tissue plasminogen activator treatment alone and in combination in a rat embolic model of stroke. Stroke (2003) 1.11
Multiparametric MRI ISODATA ischemic lesion analysis: correlation with the clinical neurological deficit and single-parameter MRI techniques. Stroke (2002) 1.11
Ascl1 lineage cells contribute to ischemia-induced neurogenesis and oligodendrogenesis. J Cereb Blood Flow Metab (2010) 1.10
Cerebrolysin enhances neurogenesis in the ischemic brain and improves functional outcome after stroke. J Neurosci Res (2010) 1.10
Angiopoietin 2 mediates the differentiation and migration of neural progenitor cells in the subventricular zone after stroke. J Biol Chem (2009) 1.10
Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo. Cancer Res (2007) 1.10
Role of AT2 receptors in the cardioprotective effect of AT1 antagonists in mice. Hypertension (2002) 1.10
Atorvastatin downregulates tissue plasminogen activator-aggravated genes mediating coagulation and vascular permeability in single cerebral endothelial cells captured by laser microdissection. J Cereb Blood Flow Metab (2006) 1.10
Reduction of the cell cycle length by decreasing G1 phase and cell cycle reentry expand neuronal progenitor cells in the subventricular zone of adult rat after stroke. J Cereb Blood Flow Metab (2006) 1.10
Impact of marital status on survival among women with invasive cervical cancer: analysis of population-based surveillance, epidemiology, and end results data. J Low Genit Tract Dis (2010) 1.09
Quantitative evaluation of BBB permeability after embolic stroke in rat using MRI. J Cereb Blood Flow Metab (2005) 1.09
Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model. Int J Cancer (2007) 1.09
Factor analysis of the National Institutes of Health Stroke Scale in patients with large strokes. Arch Neurol (2004) 1.08